fulvestrant

It is used for the treatment of postmenopausal women with a type of breast cancer that is estrogen receptor-positive, whether locally advanced or spread to other parts of the body (metastatic). It can be used alone or in combination with palbociclib.

Form: solution for injection

ATC: L02BA03

Manufacturer: ASTRAZENECA AB

It is used for the treatment of postmenopausal women with a type of estrogen receptor-positive breast cancer, whether locally advanced or spread to other parts of the body (metastatic). It can be used alone or in combination with palbociclib for women with hormone receptor-positive and human epidermal growth factor receptor 2-negative breast cancer.

Form: solution for injection

ATC: L02BA03

Manufacturer: ACCORD HEALTHCARE, S.L.U.

It is used for the treatment of advanced or metastatic breast cancer in postmenopausal women.

Form: solution for injection

ATC: L02BA03

Manufacturer: DR. REDDY'S S.R.L.

It is used for the treatment of estrogen receptor-positive breast cancer, both in postmenopausal women (alone or in combination with palbociclib) and in premenopausal women (in association with a drug called LHRH).

Form: solution for injection in pre-filled syringe

ATC: L02BA03

Manufacturer: EG S.P.A.

It is used for the treatment of postmenopausal women with a type of breast cancer that is estrogen receptor-positive, which is either locally advanced or has spread to other parts of the body (metastatic). It can be used alone or in combination with palbociclib for women with hormone receptor-positive and human epidermal growth factor receptor 2-negative breast cancer.

Form: solution for injection in pre-filled syringe

ATC: L02BA03

Manufacturer: EG S.P.A.

It is used for the treatment of postmenopausal women with a type of estrogen receptor-positive breast cancer, which may be locally advanced or spread to other parts of the body. It can be used alone or in combination with palbociclib.

Form: solution for injection in pre-filled syringe

ATC: L02BA03

Manufacturer: EVER PHARMA ITALIA S.R.L.

It is used for the treatment of postmenopausal women with a type of breast cancer that is estrogen receptor-positive, whether locally advanced or spread to other parts of the body (metastatic). It can be used alone or in combination with palbociclib.

Form: solution for injection in pre-filled syringe

ATC: L02BA03

Manufacturer: MYLAN PHARMACEUTICALS LIMITED

It is used for the treatment of postmenopausal women with a type of breast cancer that is estrogen receptor-positive, whether locally advanced or spread to other parts of the body (metastatic). It can be used alone or in combination with palbociclib for women with hormone receptor-positive and human epidermal growth factor receptor 2-negative breast cancer.

Form: solution for injection

ATC: L02BA03

Manufacturer: SANDOZ S.P.A.

It is used for the treatment of postmenopausal women with a type of estrogen receptor-positive breast cancer that is either locally advanced or has spread to other parts of the body (metastatic). It can be used alone or in combination with palbociclib for women with hormone receptor-positive and human epidermal growth factor receptor 2-negative breast cancer.

Form: solution for injection in pre-filled syringe

ATC: L02BA03

Manufacturer: ZENTIVA ITALIA S.R.L.